Yale University

Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries.

TitleUtility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries.
Publication TypeJournal Article
Year of Publication2004
AuthorsFriedland, Gerald, Salim Abdool Karim, Quarraisha Abdool Karim, Umesh Lalloo, Christopher Jack, Neel Gandhi, and Wafaa El Sadr
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Volume38 Suppl 5
PaginationS421-8
Date Published2004 Jun 1
ISSN1537-6591
KeywordsAnti-HIV Agents, Antiretroviral Therapy, Highly Active, Antitubercular Agents, Directly Observed Therapy, Drug Interactions, Drug Therapy, Combination, Health Resources, HIV Infections, Humans, Tuberculosis
AbstractThe overwhelming share of the global human immunodeficiency virus (HIV) infection and disease burden is borne by resource-limited countries. The explosive spread of HIV infection and growing burden of disease in these countries has intensified the need to find solutions to improved access to treatment for HIV infection. The epidemic of HIV infection and acquired immune deficiency syndrome (AIDS) has been accompanied by a severe epidemic of tuberculosis. Tuberculosis has become the major cause of morbidity and mortality in patients with HIV disease worldwide. Among the various models of provision of HIV/AIDS care, one logical but unexplored strategy is to integrate HIV/AIDS and tuberculosis care and treatment, including highly active antiretroviral therapy, through existing tuberculosis directly observed therapy programs. This strategy could address the related issues of inadequate access and infrastructure and need for enhanced adherence to medication and thereby potentially improve the outcome for both diseases.
DOI10.3109/00952990.2011.568081
Alternate JournalClin. Infect. Dis.

External Links